Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.050
-0.020 (-0.65%)
May 29, 2026, 4:00 PM EDT - Market closed
Altimmune Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.04 | 0.04 | 0.02 | 0.43 | -0.07 | 4.41 | |
Revenue Growth (YoY) | 80.00% | 105.00% | -95.30% | - | - | -46.12% |
Gross Profit | 0.04 | 0.04 | 0.02 | 0.43 | -0.07 | 4.41 |
Selling, General & Admin | 30.16 | 28.1 | 20.97 | 18.14 | 17.13 | 15.41 |
Research & Development | 66.8 | 66.43 | 82.23 | 65.8 | 70.54 | 74.54 |
Other Operating Expenses | - | - | - | 12.42 | - | 11.37 |
Total Operating Expenses | 96.95 | 94.53 | 103.19 | 96.36 | 87.67 | 101.32 |
Operating Income | -96.92 | -94.49 | -103.17 | -95.93 | -87.74 | -96.91 |
Interest Income | 8.9 | 7.54 | 8.07 | 7.35 | 2.87 | 0.2 |
Interest Expense | -2.7 | -1.64 | -0.01 | -0.04 | -0.01 | -0.01 |
Other Non-Operating Income (Expense) | -0.36 | -0.19 | 0.05 | 0.17 | -0.03 | -0.37 |
Total Non-Operating Income (Expense) | 5.84 | 5.72 | 8.11 | 7.48 | 2.83 | -0.18 |
Pretax Income | -91.08 | -88.77 | -95.06 | -88.45 | -84.91 | -97.09 |
Provision for Income Taxes | - | 0.68 | - | - | 0.2 | - |
Net Income | -91.08 | -88.09 | -95.06 | -88.45 | -84.71 | -97.09 |
Net Income to Common | -91.08 | -88.09 | -95.06 | -88.45 | -84.71 | -97.09 |
Shares Outstanding (Basic) | 99 | 88 | 71 | 53 | 47 | 41 |
Shares Outstanding (Diluted) | 99 | 88 | 71 | 53 | 47 | 41 |
Shares Change (YoY) | 37.10% | 24.08% | 33.35% | 13.47% | 13.67% | 61.03% |
EPS (Basic) | -0.93 | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
EPS (Diluted) | -0.93 | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 |
Shares Outstanding | 130.22 | 110.88 | 72.35 | 70.68 | 49.2 | 40.99 |
Free Cash Flow | -71.67 | -67.55 | -79.85 | -75.86 | -62.71 | -90.36 |
Free Cash Flow Per Share | -0.72 | -0.77 | -1.12 | -1.42 | -1.34 | -2.19 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -269217.00% | -230461.00% | -515860.00% | -22518.50% | 129029.00% | -2197.60% |
Profit Margin | -253003.00% | -214861.00% | -475295.00% | -20762.20% | 124578.00% | -2201.59% |
FCF Margin | -199081.00% | -164746.00% | -399240.00% | -17806.80% | 92223.50% | -2048.87% |
EBITDA | -96.81 | -94.38 | -102.93 | -95.45 | -87.25 | -96.36 |
EBITDA Margin | -268922.00% | -230188.00% | -514670.00% | -22406.60% | 128304.00% | -2185.10% |
EBIT | -96.92 | -94.49 | -103.17 | -95.93 | -87.74 | -96.91 |
EBIT Margin | -269217.00% | -230461.00% | -515860.00% | -22518.50% | 129029.00% | -2197.60% |
Effective Tax Rate | - | -0.77% | 0.00% | 0.00% | -0.23% | 0.00% |